SAVA stock pitch - 2021-11-03

Added to YB: 2021-11-03

Pitch date: 2021-11-03

Cassava Sciences, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases.

Market Cap

$62.8M

Pitch Price

$69.00

Price Target

N/A

Dividend

N/A

EV/EBITDA

0.47

P/E

-0.89

EV/Sales

N/A

Sector

Pharmaceuticals

A summary for this pitch has not been created yet.